Family Office Of America (FOFA) Property, Plant & Equipment (Net) Growth (1y) (2022 - 2023)
Family Office Of America (FOFA) Property, Plant & Equipment (Net) Growth (1y) (2022 - 2023) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.57 Bn | 193.97 Bn | 7.27 Bn | 12.44% |
| 2 | Stryker | 127.25 Bn | 123.77 Bn | 4.50 Bn | 6.92% |
| 3 | Medtronic | 118.81 Bn | 109.59 Bn | 6.41 Bn | 8.48% |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn | 19.21% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 6.67% |
| 6 | Dexcom | 34.28 Bn | 32.34 Bn | 830.00 Mn | 8.23% |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.64 Bn | 2.18 Bn | 6.21% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -1.40% |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 5.69% |
| 10 | Family Office Of America | 27.84 Mn | 27.20 Mn | 532,674.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -39.28% |
| Jun 30, 2023 | -35.77% |
| Dec 31, 2022 | -30.34% |